Bacterial Pneumonia in Older Adults

od Henig, Oryan, Kaye, Keith S.
Izdano u Infect Dis Clin North Am (2017)

Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?

od Kaye, Keith S., Patel, Twisha, Drusano, George
Izdano u Antimicrob Agents Chemother (2019)

Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae

od Thaden, Joshua T., Pogue, Jason M., Kaye, Keith S.
Izdano u Virulence (2016)

1182. Clinical Outcomes of Hospital-Associated Respiratory Virus Infections

od Petrie, Joshua G, Lauring, Adam S, Kaye, Keith S
Izdano u Open Forum Infect Dis (2019)

COVID-19 in older adults: clinical, psychosocial, and public health considerations

od Mills, John P., Kaye, Keith S., Mody, Lona
Izdano u JCI Insight (2020)

Antibiotic Resistance in Urinary Isolates of Escherichia coli from College Women with Urinary Tract Infections

od Olson, Ronald P., Harrell, Lizzie J., Kaye, Keith S.
Izdano 2009

Aminoglycoside Use in Intensive Care Units and Aminoglycoside Nephrotoxicity

od Pogue, Jason M., Potoski, Brian A., Kaye, Keith S.
Izdano 2010

1025 Impact of Nasal Decontamination with Nasal Iodine as part of a Preoperative Surgical Site Infection (SSI) Prevention Bundle in Orthopedic Implant Surgeries

od Neelakanta, Anupama, Bhargava, Ashish, Kaye, Keith, Dhar, Sorabh
Izdano u Open Forum Infect Dis (2014)

Risk Factors for Recovery of Ampicillin-Sulbactam-Resistant Escherichia coli in Hospitalized Patients

od Kaye, Keith S., Harris, Anthony D., Gold, Howard, Carmeli, Yehuda
Izdano 2000

Reference Group Choice and Antibiotic Resistance Outcomes

od Kaye, Keith S., Engemann, John J., Mozaffari, Essy, Carmeli, Yehuda
Izdano 2004

The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy

od Lee, Rachael A, Kaye, Keith S, Cutter, Gary, Camins, Bernard
Izdano u Open Forum Infect Dis (2017)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria

od Singh, Nivedita, Nguyen, Logan, Rybak, Michael J, Kaye, Keith S
Izdano u Open Forum Infect Dis (2018)

Hospital Associated Respiratory Virus Infection in Children and Adults: It Does Not Just Occur During Cold and Flu Season

od Petrie, Joshua G, Lauring, Adam S, Martin, Emily T, Kaye, Keith S
Izdano u Open Forum Infect Dis (2020)

318. Deferring Amputation in Diabetic Foot Osteomyelitis: Doing more Harm than Good?

od Zhou, Shiwei, Schmidt, Brian M, Henig, Oryan, Kaye, Keith S
Izdano u Open Forum Infect Dis (2020)

Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?

od Zhou, Shiwei, Schmidt, Brian M, Henig, Oryan, Kaye, Keith S
Izdano u Open Forum Infect Dis (2021)

Surgical site infection prophylaxis strategies for cardiothoracic surgery: a decision-analytic model

od Kaye, Keith S., Devine, Scott T., Ford, Kimbal D., Anderson, Deverick J.
Izdano 2012

Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review

od Lashinsky, Jennifer N., Henig, Oryan, Pogue, Jason M., Kaye, Keith S.
Izdano u Infect Dis Ther (2017)

Meropenem–vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria

od Patel, Twisha S, Pogue, Jason M, Mills, John P, Kaye, Keith S
Izdano u Future Microbiol (2018)

Shifting Gears: The Future of Polymyxin Antibiotics

od Lenhard, Justin R., Bulman, Zackery P., Tsuji, Brian T., Kaye, Keith S.
Izdano u Antibiotics (Basel) (2019)

2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negat...

od Tran, Kieu-Nhi, Mynatt, Ryan, Kaye, Keith S, Pogue, Jason M
Izdano u Open Forum Infect Dis (2019)